[go: up one dir, main page]

BRPI0507334A - processo para a preparação de -1(2s,3s)-2-benzidril-n-(5-terc-butil-2-metoxibenzila)q uinuclidin-3-amina - Google Patents

processo para a preparação de -1(2s,3s)-2-benzidril-n-(5-terc-butil-2-metoxibenzila)q uinuclidin-3-amina

Info

Publication number
BRPI0507334A
BRPI0507334A BRPI0507334-0A BRPI0507334A BRPI0507334A BR PI0507334 A BRPI0507334 A BR PI0507334A BR PI0507334 A BRPI0507334 A BR PI0507334A BR PI0507334 A BRPI0507334 A BR PI0507334A
Authority
BR
Brazil
Prior art keywords
amine
benzhydryl
methoxybenzyl
tert
butyl
Prior art date
Application number
BRPI0507334-0A
Other languages
English (en)
Inventor
Patricia Ann Basford
Ronald James Post
Julian Duncan Smith
Geraldine Patricia Taber
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BRPI0507334A publication Critical patent/BRPI0507334A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCESSO PARA A PREPARAçãO DE 1-(2S,3S)-2-BENZIDRIL-N-(5-TERC-BUTI-2-METOXIBENZILA)QUI NUCLIDIN-3-AMINA. A presente invenção refere-se a um processo aperfeiçoado para a preparação de (2S,3S)-2-benzidril-N-(5-terc-butil-2-metoxibenzila) quinucli-din-3-amina (a partir daqui, nesta exposição "composto da fómula l") e os seus sais farmaceuticamente aceitáveis. Especificamente, a invenção é direcionada a uma síntese aperfeiçoada do sal de citrato do monoidrato do composto da fórmula la.
BRPI0507334-0A 2004-02-02 2005-01-26 processo para a preparação de -1(2s,3s)-2-benzidril-n-(5-terc-butil-2-metoxibenzila)q uinuclidin-3-amina BRPI0507334A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54132304P 2004-02-02 2004-02-02
PCT/IB2005/000221 WO2005075473A1 (en) 2004-02-02 2005-01-26 Process for preparation of 1-(2s,3s)-2-benzhydr yl-n-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine

Publications (1)

Publication Number Publication Date
BRPI0507334A true BRPI0507334A (pt) 2007-07-03

Family

ID=34837478

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507334-0A BRPI0507334A (pt) 2004-02-02 2005-01-26 processo para a preparação de -1(2s,3s)-2-benzidril-n-(5-terc-butil-2-metoxibenzila)q uinuclidin-3-amina

Country Status (22)

Country Link
US (1) US20090099364A1 (pt)
EP (1) EP1713801B1 (pt)
JP (1) JP2007519710A (pt)
KR (1) KR100812046B1 (pt)
CN (1) CN1914202A (pt)
AR (1) AR047523A1 (pt)
AT (1) ATE380811T1 (pt)
AU (1) AU2005210259A1 (pt)
BR (1) BRPI0507334A (pt)
CA (1) CA2554360A1 (pt)
CY (1) CY1107141T1 (pt)
DE (1) DE602005003791T2 (pt)
DK (1) DK1713801T3 (pt)
ES (1) ES2296131T3 (pt)
IL (1) IL176817A0 (pt)
NO (1) NO20063268L (pt)
PL (1) PL1713801T3 (pt)
PT (1) PT1713801E (pt)
RU (1) RU2320659C9 (pt)
SI (1) SI1713801T1 (pt)
WO (1) WO2005075473A1 (pt)
ZA (1) ZA200605784B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2332997C2 (ru) 2004-01-30 2008-09-10 Пфайзер Продактс Инк. АНТИМИКРОБНЫЕ КОНСЕРВАНТЫ ДЛЯ ДОСТИЖЕНИЯ МУЛЬТИДОЗОВЫХ РЕЦЕПТУР С ИСПОЛЬЗОВАНИЕМ β-ЦИКЛОДЕКСТРИНОВ ДЛЯ ЖИДКИХ ЛЕКАРСТВЕННЫХ ФОРМ
CN102892763B (zh) * 2010-05-19 2016-03-09 桑多斯股份公司 泊沙康唑及泊沙康唑中间体的纯化
BR112012029225B1 (pt) 2010-05-19 2020-10-27 Sandoz Ag processo para a preparação de um composto quiral, composto quiral e uso de um composto quiral
BR112012029226A2 (pt) 2010-05-19 2015-10-20 Sandoz Ag processo para a preparação de um composto quiral, composto quiral cristalino, sal de hcl do composto quiral cristalino, composto quiral e uso do composto
US9446029B2 (en) 2010-07-27 2016-09-20 Colorado State University Research Foundation Use of NK-1 receptor antagonists in management of visceral pain
DE102011100534A1 (de) 2011-05-05 2012-11-08 Howaldtswerke-Deutsche Werft Gmbh Verfahren zum Betreiben einer Reformer-Brennstoffzellenanlage
WO2012172015A1 (en) 2011-06-16 2012-12-20 Sandoz Ag Process for the preparation of a chiral compound
CN108341811A (zh) * 2017-01-23 2018-07-31 科贝源(北京)生物医药科技有限公司 马罗皮坦杂质的制备方法
CN108341812A (zh) * 2017-01-23 2018-07-31 科贝源(北京)生物医药科技有限公司 一种含奎宁环化合物的制备方法
CN106977512B (zh) * 2017-05-04 2019-01-01 海门慧聚药业有限公司 制备马罗匹坦游离碱的方法
CN110577522B (zh) * 2018-06-07 2022-12-27 东莞市东阳光动物保健药品有限公司 马罗匹坦柠檬酸盐新晶型及其制备方法
CN109320510B (zh) * 2018-11-27 2021-04-27 江苏慧聚药业有限公司 一种马罗匹坦游离碱的制备方法
CN112979639B (zh) * 2019-12-16 2025-08-08 凯默斯医药科技(上海)有限公司 一种马罗皮坦新晶型及其制备方法
KR102666745B1 (ko) * 2023-09-06 2024-05-17 주식회사 에스아이켐 시선 유도봉 및 표지병의 노면부착용 에폭시계 접착제 조성물 및 이를 이용한 시선 유도봉 및 표지병의 시공방법
WO2025172911A1 (en) * 2024-02-16 2025-08-21 Teadus Pharmaceuticals Pvt. Ltd A process for the preparation of (2s,3s)-2-benzhydryl- n-(5-tert-butyl-2-methoxybenzyl) quinuclidin-3-amine and pharmaceutically acceptable salts thereof
CN119285626B (zh) * 2024-10-11 2025-12-09 中国农业大学 一种止呕药化合物的制备方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0733386B2 (ja) * 1991-05-31 1995-04-12 フアイザー・インコーポレイテツド キヌクリジン誘導体
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
PE8798A1 (es) * 1995-07-17 1998-03-02 Pfizer Procedimiento de separacion de los enantiomeros del 1-azabiciclo[2.2.2] octan-3-amina, 2-(difenilmetil) -n- [[2-metoxi-5-(1-metiletil) fenil] metil]
US6255320B1 (en) * 1999-06-01 2001-07-03 Pfizer Inc. Polymorphs of a crystalline azo-bicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
US6861526B2 (en) * 2002-10-16 2005-03-01 Pfizer Inc. Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine

Also Published As

Publication number Publication date
EP1713801A1 (en) 2006-10-25
ATE380811T1 (de) 2007-12-15
RU2320659C9 (ru) 2008-07-20
DE602005003791T2 (de) 2008-05-29
IL176817A0 (en) 2006-10-31
RU2320659C1 (ru) 2008-03-27
CN1914202A (zh) 2007-02-14
PL1713801T3 (pl) 2008-04-30
DE602005003791D1 (de) 2008-01-24
EP1713801B1 (en) 2007-12-12
ZA200605784B (en) 2007-11-28
AR047523A1 (es) 2006-01-25
KR100812046B1 (ko) 2008-03-10
US20090099364A1 (en) 2009-04-16
CY1107141T1 (el) 2012-10-24
AU2005210259A1 (en) 2005-08-18
PT1713801E (pt) 2008-02-11
WO2005075473A1 (en) 2005-08-18
KR20060127966A (ko) 2006-12-13
CA2554360A1 (en) 2005-08-18
ES2296131T3 (es) 2008-04-16
SI1713801T1 (sl) 2008-04-30
NO20063268L (no) 2006-08-15
DK1713801T3 (da) 2008-03-17
JP2007519710A (ja) 2007-07-19

Similar Documents

Publication Publication Date Title
BRPI0507334A (pt) processo para a preparação de -1(2s,3s)-2-benzidril-n-(5-terc-butil-2-metoxibenzila)q uinuclidin-3-amina
NO974163D0 (no) Ester av 5-aminolevulinsyre som fotosensibiliserings-middel i fotokjemoterapi
BR0312729A (pt) Novos derivados de indol-3-enxofre
BRPI0509795A (pt) composto ou um sal farmacologicamente aceitável do mesmo, composição farmacêutica, uso do composto ou sal farmacologicamente aceitável do mesmo, e, método para promover osteogênese, supressão de ressorção óssea e/ou melhoramento da densidade óssea
EP1893246A4 (en) STEREOSELECTIVE SYNTHESIS OF AMINO ACID ANALOGUE FOR TUMOR IMAGING
TW200728307A (en) Novel spirochromanone derivatives
BRPI0015610C1 (pt) composto derivado de 3,3-difenilpropilamina, processo para preparação do mesmo, utilização de intermediários na obtenção do referido composto
MY151295A (en) Pyrimidyl indoline compound
BRPI0416216A (pt) composto de glicoimidazol e polihidroxiciclohexenila e método para sintetizar composto de glicoimidazol e polihidroxiciclohexenila, métodos para inibir glicocerebrosidase, para aumentar a atividade de glicocerebrosidase e para estabilizar glicocerebrosidade, composição farmacêutica, métodos para inibir uma -glicosidade, e para tratar doença de gaucher, derivado de glicoimidazol e derivados de polihidroxiciclohexilamina
EP2620145A3 (en) 2,5-dihydroxybenzene compounds for the treatment of of cancer of an organ
PE20061319A1 (es) Cristales formados de clorhidrato de {[(2r)-7-(2,6-diclorofenil)-5-fluoro-2-3-dihidro-1-benzofurano-2-il]metil}amina
BRPI0515628A (pt) composto de 2-morfolina-4-pirimidona
IL169257A0 (en) Cycloalkene dicarboxylic acid compounds as anti-infammatory, immunomodulatory and anti-proliferatory agents
EA200800303A1 (ru) Применение производных и аналогов тиазола при нарушениях, вызванных свободными жирными кислотами
BRPI0515851A (pt) composto de pirimidona
BRPI0416746A (pt) processo de sìntese do perindopril e de seus sais farmaceuticamente aceitáveis
BRPI0409095A (pt) processos de sìntese do ácido (2s)-indolina-2-carboxìlico, e aplicação para a sìntese do perindopril
MX2009011449A (es) Agente terapeutico o profilactico para disquinesia.
WO2006051314A8 (en) Guanidine derivatives as inhibitors of ddah
MX2009006003A (es) Composicion que contiene derivados de aurona con fines de diagnostico.
BR0316751A (pt) Análogos de gabapentina para fibromialgia e outros distúrbios relacionados
EA201170528A1 (ru) Производные 1-бутил-2-гидроксиаралкилпиперазина и их применения в качестве лекарственного средства против депрессии
BR0214971A (pt) Processo para a produção de um imunossupressor
BRPI0413169A (pt) processo de sìntese do perindopril e de seus sais farmaceuticamente aceitáveis
DE602005017629D1 (de) Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A E 6A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2099 DE 29/03/2011.